Lyra Therapeutics, Inc. (LYRA)

1.44 -0.01 (-0.69%) USD  |  NASDAQ  |  Feb 24, 15:47
More

Lyra Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for LYRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Protokinetix, Inc. Upgrade
GB Sciences, Inc. Upgrade